Literature DB >> 15741567

As genetic tests move into the mainstream, challenges await for doctors and patients.

Sarah L Zielinski.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15741567     DOI: 10.1093/jnci/97.5.334

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Genomics in the era of molecular ophthalmology: reflections on the National Ophthalmic Disease Genotyping Network (eyeGENE).

Authors:  Brian P Brooks; Ian M Macdonald; Santa J Tumminia; Nizar Smaoui; Delphine Blain; Ajaina A Nezhuvingal; Paul A Sieving
Journal:  Arch Ophthalmol       Date:  2008-03

2.  Effect of misreported family history on Mendelian mutation prediction models.

Authors:  Hormuzd A Katki
Journal:  Biometrics       Date:  2006-06       Impact factor: 2.571

Review 3.  Use of Genetic Testing for Primary Immunodeficiency Patients.

Authors:  Jennifer R Heimall; David Hagin; Joud Hajjar; Sarah E Henrickson; Hillary S Hernandez-Trujillo; Yuval Tan; Lisa Kobrynski; Kenneth Paris; Troy R Torgerson; James W Verbsky; Richard L Wasserman; Elena W Y Hsieh; Jack J Blessing; Janet S Chou; Monica G Lawrence; Rebecca A Marsh; Sergio D Rosenzweig; Jordan S Orange; Roshini S Abraham
Journal:  J Clin Immunol       Date:  2018-04-19       Impact factor: 8.317

4.  Multiple diseases in carrier probability estimation: accounting for surviving all cancers other than breast and ovary in BRCAPRO.

Authors:  Hormuzd A Katki; Amanda Blackford; Sining Chen; Giovanni Parmigiani
Journal:  Stat Med       Date:  2008-09-30       Impact factor: 2.373

5.  Incorporating medical interventions into carrier probability estimation for genetic counseling.

Authors:  Hormuzd A Katki
Journal:  BMC Med Genet       Date:  2007-03-22       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.